| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0123c1dfd65caa2cf0e4ad7ebf33491 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-12 |
| filingDate |
2010-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba955cf2b8cf4fee691d5c67eb86b598
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_280623c33f00415a315b076e2aa95da6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_496073ef359dc95e715a77cfb8dd4154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1581a608444f519d922f33be6514ead7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0efaf04f7a992b6bbdb57061b298dbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9af7427da47d07a07bf09227da7211d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50f7d5785018dad07a3959f1b715895a |
| publicationDate |
2014-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20140015157-A |
| titleOfInvention |
ATV activity inhibitor |
| abstract |
Pharmaceutical compounds The present invention relates to a series of compounds with specific activity as inhibitors of serine-threonine kinase AKR. Also provided are pharmaceutical compositions comprising the compounds and methods for treating cancer. |
| priorityDate |
2009-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |